financetom
Business
financetom
/
Business
/
Rubrik Insider Sold Shares Worth $308,873, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rubrik Insider Sold Shares Worth $308,873, According to a Recent SEC Filing
Jun 13, 2025 2:48 PM

05:24 PM EDT, 06/13/2025 (MT Newswires) -- Kiran Kumar Choudary, Chief Financial Officer, on June 11, 2025, sold 3,500 shares in Rubrik ( RBRK ) for $308,873. Following the Form 4 filing with the SEC, Choudary has control over a total of 524,165 Class A common shares of the company, with 524,165 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1943896/000141588925017258/xslF345X05/form4-06132025_090654.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GSK Reports Positive Results from Phase 3 Trial for Blenrep in Multiple Myeloma Treatment
GSK Reports Positive Results from Phase 3 Trial for Blenrep in Multiple Myeloma Treatment
Nov 15, 2024
07:05 AM EST, 11/14/2024 (MT Newswires) -- GSK (GSK) said Thursday that the interim analysis of the DREAMM-7 head-to-head phase three trial evaluating Blenrep, or belantamab mafodotin, in combination with bortezomib plus dexamethasone, or BorDex, as a second-line or later treatment for relapsed or refractory multiple myeloma showed positive headline results. The trial met its key secondary endpoint of overall...
Cash-strapped US farmers switch to generic crop chemicals, in blow to big manufacturers
Cash-strapped US farmers switch to generic crop chemicals, in blow to big manufacturers
Nov 15, 2024
(Reuters) - U.S. farmers struggling with slumping incomes and depressed grain prices have been switching to cheaper generic pesticides and fungicides as they plan for spring planting next year, which market analysts said could hit the bottom lines of agrichemical companies like Bayer. Signs of these financial impacts are already emerging. Bayer shares fell sharply to a 20-year low on...
BeiGene to Rename as BeOne Medicines
BeiGene to Rename as BeOne Medicines
Nov 15, 2024
07:08 AM EST, 11/14/2024 (MT Newswires) -- BeiGene ( BGNE ) said Thursday it plans to change its name to BeOne Medicines, subject to shareholder approval. Once the name change is approved, the company's Nasdaq ticker will change to ONC. The name change is part of the company's global oncology growth strategy. Price: 222.99, Change: -4.06, Percent Change: -1.79 ...
Merck signs up to $3.3 bln cancer drug deal with China-based LaNova
Merck signs up to $3.3 bln cancer drug deal with China-based LaNova
Nov 15, 2024
Nov 14 (Reuters) - Merck ( MRK ) has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and sell an experimental cancer drug, the two companies said on Thursday. The deal allows Merck ( MRK ) to take over development of LaNova's LM-299, a drug candidate targeting a protein called PD-1, which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved